UBS Group’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2M | Buy |
|
|||||
|
2025
Q2 | $940K | Sell |
|
|||||
|
2025
Q1 | $828K | Buy |
|
|||||
|
2024
Q4 | $474K | Buy |
|
|||||
|
2024
Q3 | $69.1K | Buy |
|
|||||
|
2024
Q2 | $66.3K | Buy |
|
|||||
|
2024
Q1 | $56.4K | Sell |
|
|||||
|
2023
Q4 | $48.2K | Buy |
|
|||||
|
2023
Q3 | $8.96K | Sell |
|
|||||
|
2023
Q2 | $14.3K | Sell |
|
|||||
|
2023
Q1 | $33.8K | Buy |
|
|||||
|
2022
Q4 | $14.6K | Buy |
|
|||||
|
2022
Q3 | $8K | Sell |
|
|||||
|
2022
Q2 | $13K | Sell |
|
|||||
|
2022
Q1 | $75K | Buy |
|
|||||
|
2021
Q4 | $53K | Buy |
|
|||||
|
2021
Q3 | $46K | Sell |
|
|||||
|
2021
Q2 | $94K | Sell |
|
|||||
|
2021
Q1 | $557K | Buy |
|
|||||
|
2020
Q4 | $95K | Sell |
|
|||||
|
2020
Q3 | $1.6M | Sell |
|
|||||
|
2020
Q2 | $1.66M | Sell |
|
|||||
|
2020
Q1 | $1.39M | Buy |
|
|||||
|
2019
Q4 | $142K | Sell |
|
|||||
|
2019
Q3 | $2.57M | Buy |
|
|||||
|
2019
Q2 | $180K | Sell |
|
|||||
|
2019
Q1 | $982K | Sell |
|
|||||
|
2018
Q4 | $3.91M | Buy |
|
|||||
|
2018
Q3 | $2.73M | Buy |
|
|||||
|
2018
Q2 | $2.41M | Sell |
|
|||||
|
2018
Q1 | $4.86M | Sell |
|
|||||
|
2017
Q4 | $19M | Buy |
|
|||||
|
2017
Q3 | $5.52M | Sell |
|
|||||
|
2017
Q2 | $5.25M | Sell |
|
|||||
|
2017
Q1 | $2.75M | Sell |
|
|||||
|
2016
Q4 | $5.14M | Buy |
|
|||||
|
2016
Q3 | $7.6M | Sell |
|
|||||
|
2016
Q2 | $4.23M | Buy |
|
|||||
|
2016
Q1 | $3.59M | Buy |
|
|||||
|
2015
Q4 | $7.83M | Sell |
|
|||||
|
2015
Q3 | $12.4M | Buy |
|
|||||
|
2015
Q2 | $18.6M | Buy |
|
|||||
|
2015
Q1 | $28.4M | Buy |
|
|||||
|
2014
Q4 | $7.79M | Buy |
|